Skip to content

13F-HR filed by Squadron Capital Management LLC

Squadron Capital Management LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:33:40 UTC, with 45 holding rows worth $398,466,273.

Accession
0002050709-26-000036
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 45 entries on the cover page, a total value of $398,466,273 stated on the cover page (in dollars after the unit check, H1), rows summing to $398,466,273 with VALUE read as dollars as filed, 13F file number 028-26573. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KODIAK SCIENCES INC50015M109COM420,000$39,816,000dollars as filed
C4 THERAPEUTICS INC12529R107COM STK9,318,683$31,031,214dollars as filed
COGENT BIOSCIENCES INC19240Q201COM915,000$29,298,300dollars as filed
KODIAK SCIENCES INC50015M109COM270,000$25,596,000dollars as filedcall
SILENCE THERAPEUTICS PLC82686Q101ADS2,085,000$22,789,050dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK6,827,905$18,913,297dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM425,000$17,255,000dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock785,000$14,169,250dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM1,000,000$13,470,000dollars as filed
RELMADA THERAPEUTICS INC75955J402COMMON STOCK3,500,000$13,195,000dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS340,000$12,940,400dollars as filed
PHARVARIS NVN69605108COMMON STOCK400,000$12,688,000dollars as filed
Adlai Nortye00704R109SPONSORED ADS764,876$12,238,016dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK305,000$9,848,450dollars as filed
INVENTIVA SA46124U107ADS2,400,000$8,856,000dollars as filed
DISC MEDICINE INC COM254604101Stock134,500$8,804,370dollars as filedcall
COGENT BIOSCIENCES INC19240Q201COM265,000$8,485,300dollars as filedcall
AVALO THERAPEUTICS INC05338F306COMMON STOCK450,000$6,898,500dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock1,200,000$6,312,000dollars as filed
REZOLUTE INC76200L309COMMON STOCK1,323,500$5,479,290dollars as filedcall
ASSEMBLY BIOSCIENCES INC045396207COMMON STOCK225,000$5,285,250dollars as filed
ADAGENE INC005329107CMN1,616,618$5,173,178dollars as filed
CRESCENT BIOPHARMA INCG2545C104COMMON STOCK350,000$5,106,500dollars as filed
Yarrow Bioscience, Inc.92941V407Common Stock, $0.0001 par value225,000$5,067,000dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK1,200,000$4,992,000dollars as filed
TCGX ACQUISITION CORPG8708J109COM370,220$4,631,452dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock323,570$4,342,309dollars as filed
ARRIVENT BIOPHARMA INC04272N102COM142,500$4,314,900dollars as filedcall
INHIBIKASE THERAPEUTICS INC45719W205COMMON STOCK2,000,000$4,110,000dollars as filed
PALISADE BIO INC696389402COMMON STOCK3,000,000$4,050,000dollars as filed
TANGO THERAPEUTICS INC87583X109COM150,000$3,742,500dollars as filed
JANUX THERAPEUTICS INC47103J105COM215,000$3,715,200dollars as filed
SAVARA INC805111101COM675,000$3,483,000dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock225,000$3,019,500dollars as filedcall
QUINCE THERAPEUTICS INC COM22053A305Stock90,000$2,790,900dollars as filed
JATT III ACQUISITION CORPG5080G109COM250,000$2,755,000dollars as filed
SCYNEXIS INC811292309COM515,045$2,544,322dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS180,000$1,967,400dollars as filedcall
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK1,400,000$1,946,000dollars as filed
LIPOCINE INC NEW53630X203COM NEW810,000$1,782,000dollars as filed
BIOAGE LABS INC COM09077V100Stock250,000$1,772,500dollars as filedcall
PEPGEN INC COM713317105Stock600,000$1,452,000dollars as filed
C4 THERAPEUTICS INC12529R107COM STK400,000$1,332,000dollars as filedcall
JATT II ACQUISITION CORPG50765109ORD SHS65,000$730,925dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK100,000$277,000dollars as filedcall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002050709-26-000036this filing2026-11-16